We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Putting Trial Transparency Ahead of Public’s Interest, Pharma Says
EMA Putting Trial Transparency Ahead of Public’s Interest, Pharma Says
October 10, 2013
Pharma continues to push back against a European Medicines Agency plan to make more trial data publicly available, saying it will undermine patient privacy and medical research.